at bead surfaces or sites of TCR ligation then displaces the bound IP 4 (fig. S6A ). The ability of soluble PIP 3 to modulate Itk binding to PIP 3 coated beads with a dose response similar to that of IP 4 
(fig. S5, C and D) is consistent with this
"induced-fit model." An attractive alternative model is suggested by our finding that the Itk PH domain aggregates with other Itk PH domain fragments or full-length Itk in a manner unaffected by 10 mM IP 4 (Fig. 4F) . IP 4 binding to one PH domain might induce conformational changes in the other subunits that increase their affinities for PIP 3 allosterically ( fig. S6B) . Future research will distinguish between these models and conclusively determine the precise mechanism by which IP 4 augments PH domain interactions with PIP 3 .
Our results show that IP 4 acts as an essential mediator of Itk and PLC-g1 activation and DAG production in DP thymocytes through Itk recruitment to sites of TCR engagement ( fig. S7 ). This IP 4 function is essential for TCR signaling during thymocyte positive selection. Besides Itk, low-micromolar concentrations of IP 4 also augmented PIP 3 interactions of several other PH domain proteins, including Tec and GAP1 IP4BP (3, (13) (14) (15) (Fig. 4 , A and B). In particular, IP 4 augmented PIP 3 binding of GAP1 IP4BP PH domain fragments ( fig. S5E ). Dysregulation of several IP 4 -regulated PH domain proteins could explain the phenotypic differences between ItpkB -/-(2, 3) and Itk -/-mice (6) . By contrast, PH domain-dependent PLC-g1 binding to PIP 3 -coated beads was unaffected by IP 4 (Fig. 4 , A and B). Thus, positive or negative regulation of PIP 3 binding through soluble IP 4 may serve as a general mechanism that controls membrane recruitment of a group of PIP 3 -binding proteins in a specific manner (Fig. 4 and fig. S5 ) (16) . It will be interesting to determine whether defects in this mechanism of IP 4 action contribute to the impaired B cell development and function in ItpkB -/-mice, as reported in (17) . PIP 3 Obesity is a serious international health problem that increases the risk of several common diseases. The genetic factors predisposing to obesity are poorly understood. A genome-wide search for type 2 diabetes-susceptibility genes identified a common variant in the FTO (fat mass and obesity associated) gene that predisposes to diabetes through an effect on body mass index (BMI). An additive association of the variant with BMI was replicated in 13 cohorts with 38,759 participants. The 16% of adults who are homozygous for the risk allele weighed about 3 kilograms more and had 1.67-fold increased odds of obesity when compared with those not inheriting a risk allele. This association was observed from age 7 years upward and reflects a specific increase in fat mass.
O besity is a major cause of morbidity and mortality, associated with an increased risk of type 2 diabetes mellitus, heart disease, metabolic syndrome, hypertension, stroke, and certain forms of cancer. It is typically measured clinically with the surrogate measure of body mass index (BMI), calculated as weight divided by height squared. Individuals with a BMI ≥ 25 kg/m 2 are classified as overweight, and those with a BMI ≥ 30 kg/m 2 are considered obese. The prevalence of obesity is increasing worldwide, probably as the result of changed lifestyle. Twin and adoption studies have demonstrated that genetic factors play an important role in influencing which individuals within a population are most likely to develop obesity in response to a particular environment (2). However, despite considerable efforts, there are, as yet, no examples of common genetic variants for which there is widely replicated evidence of association with obesity in the general population. Monogenic forms of obesity at present account for~7% of children with severe, young-onset obesity (3), but as this severity of obesity is only seen in <0.01% of the population, these mutations are rare in the general population. Recent attempts to identify gene variants predisposing to common, polygenic obesity have proven controversial. Initial reports of promising associations between common variants in the GAD2 (4-7), ENPP1 (5, 8, 9 ) and INSIG2 (9-12) genes and altered BMI have not been widely replicated.
Obesity is a major risk factor for type 2 diabetes, and variants that influence the development of obesity may also predispose to type 2 diabetes. ). Analysis of BMI as a continuous trait was possible in the initial diabetes cases and in all replication samples but not in the initial control samples. The diabetes-risk alleles at FTO were strongly associated with increased BMI (Table 1 ). In the replication samples, the association between FTO SNPs and type 2 diabetes was abolished by adjustment for BMI (OR = 1.03; 95% CI = 0.96 to 1.10; P = 0.44), which suggests that the association of these SNPs with T2D risk is mediated through BMI. The major signal for association with BMI coincides perfectly with that for type 2 diabetes, and rs9939609 represents a cluster of 10 SNPs in the first intron of FTO that are associated with both traits (Fig. 1) . All BMI-associated SNPs (P ranging from 1 × 10 −4 to 1 × 10 In all adult population-based studies, we found that the type 2 diabetes-associated A allele of rs9939609 (frequency 39%) was associated with increased BMI (Table 1) ). In each study, carriers of two A alleles had a higher BMI than heterozygote individuals; when we compared the additive model to a general model in each study, there was no consistent evidence for departure from an additive model. Because there was no evidence of heterogeneity (I 2 = 0%) across the adult studies (14), we combined them using the inverse variance method to pool continuous data (Z scores) and the Mantel-Haenszel method for binary data. Each additional copy of the rs9939609 A allele was associated with a BMI increase of a mean of 0.10 Z-score units (95% CI = 0.08 to 0.12; P = 2 × 10
. When these data were combined with those from the case-control samples (a total of 30,081 participants), the statistical confidence of the association was further increased (P = 3 × 10 −35 ) ( Table 1 and fig. S1 ). When we applied a Bonferroni correction for the number of tests performed in the initial genome-wide scan (~400,000), the association remained significant (P = 1.2 × 10
−29
). This association was present in adults of all ages (Table 1) and of both sexes (fig. S1B and S1C), with no difference between males and females (P = 0.13).
Although BMI is a continuous trait, standard cut-offs are used to assess the burden of increased body weight on health. Hence, we assessed whether the inheritance of the FTO SNP rs9939609 altered the risk of being either overweight or obese compared with being normal weight (<25 kg/m 2 ). In all the studies, the A allele was associated with increased odds of being overweight ( Fig. 2A) and also of being obese ( Fig. 2B and table S2 ). In a meta-analysis of the population-based studies, the per-A allele odds ratio (OR) for obesity in the adult general population was 1.31 (95% CI = 1.23 to 1.39; P = 6 × 10
); for overweight, it was 1.18 (95% CI = 1.13 to 1.24; P = 1 × 10
−12
). When participants from the type 2 diabetes case and *ALSPAC children are offspring of the participants included in the adult study (Table 1) , and data are shown at five available ages. NFBC1966 children are the same participants as those in the adult study (Table 1) . †ALSPAC birth data are for the same participants as those in the children study. NFBC1966 birth data are for the same participants as those in the children and adult studies. Non-singleton births and individuals born at gestation <36 weeks were excluded from the birth-weight analysis. ; overweight: OR = 1.18; 95% CI = 1.14 to 1.23], P = 2 × 10
−17
). Individuals homozygous for the A allele at rs9939609 (16% of the population) are at substantially increased risk of being overweight (OR = 1.38; 95% CI = 1.26 to 1.52]; P = 4 × 10 ) compared with those homozygous for the low-risk T allele (37% of the population). The extent of the variance in BMI explained by rs9939609 was~1%, and the population attributable risk was 20.4% for obesity and 12.7% for overweight.
Childhood obesity is also increasing rapidly worldwide and is a cause of considerable concern (15). To determine the age at which the association of FTO SNP rs9939609 with BMI first becomes evident, we analyzed two large birth cohorts for which suitable measures were available from birth to early adolescence. These included 7477 UK children from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort who had anthropometric measures at birth and at 7, 8, 9, 10, and 11 years of age and 4320 children from the Northern Finland 1966 birth cohort (NFBC1966) with birth measures as well as height and weight available at 14 years. rs9939609 was not associated with birth weight (Table 2) or ponderal index at birth (table S3A) in either cohort. In children from the ALSPAC study, each copy of the rs9939609 A allele was associated with an increase in BMI by 0.08 Z-score units (95% CI = 0.04 to 0.12; P = 3 × 10 Table 2) . At all ages, the A allele was associated with an increased risk of childhood obesity (e.g., OR per-A allele at age 11 years = 1.35; CI = 1.14, 1.61; P = 6 × 10 −4 ) and of being overweight (e.g., OR per-A allele at age 11 years = 1.27; CI = 1.16 to 1.39; P = 2 × 10 −7 ), as defined by age-specific BMI (table S2). In the Finnish cohort, each copy of the rs9939609 A allele was associated with an increase in BMI by 0.05 Z-score units (95% CI = 0.003 to 0.09; P = 0.04;~0.1 kg/m 2 ) at the age of 14 years (Table 2 ). We conclude therefore that FTO SNP rs9939609 is not associated with changes in fetal growth but is associated with changes in BMI and obesity in children by the age of 7, changes that persist into the prepubertal period and beyond.
BMI is a convenient surrogate measure for obesity, but it may be influenced by changes in height, bone mass, and lean mass, as well as adiposity. We used additional anthropometric measurements available in the study samples to address this issue. In all population-based cohorts, the rs9939609 A allele was associated with higher weight (overall per-A allele increase = 
Per-A allele odds ratio for overweight vs normal (95% CI)
Overall ;~1.2 kg in adults) (tables S3B and S3C), but there was no difference in height (tables S3C and S3D). Consistent with this observation, we found evidence for higher waist circumference (overall per-A allele = 0.08 Z-score units; 95% CI = 0.05 to 0.11; P = 4 × 10
;~1 cm) (table S3E) and higher subcutaneous mass assessed by skinfold measures (per-A allele difference = 0.11 Z-score units; 95% CI = 0.06 to 0.16; P = 2 × 10 −5 ) (table S3F). In the children from the ALSPAC study, dual-energy x-ray absorptiometry (DEXA)-derived measures of fat mass and lean mass were available at age 9. The association of rs9939609 A allele with weight was almost exclusively attributable to changes in fat mass, with a per-allele difference of 0.12 Zscore units (95% CI = 0.08 to 0.16; P = 6 × 10 ), equivalent to a 14% difference across the three genotype groups) (Fig. 2C) . Genotype-related differences in lean mass were, in contrast, a modest 0.04 Z-score units (95% CI = 0.005 to 0.08; P = 0.03), which is equivalent to a 1% increase across the three genotype groups) (Fig.  2D) . Therefore, the association of genetic variation at FTO with BMI results from longitudinal changes in fat mass that, on the basis of anthropometric measures, reflect both increased waist circumference and subcutaneous fat.
One important potential source of falsepositive associations in genetic studies is population stratification. We do not believe this is likely to be important in the association of the FTO SNP with BMI or type 2 diabetes. In all study cohorts, any individuals who were not European whites were excluded. In addition the cohorts were all recruited from single countries, with the majority coming from specific small geographically defined regions, and the analysis for association was done only within individual cohorts. Analysis of the FTO signal does not support this association resulting from population stratification. In the original genome-wide association study, the principal component analysis (16) implemented in EIGENSTRAT (17) made no difference to the evidence for association for type 2 diabetes (P = 5.3 × 10 −8 with EIGENSTRAT adjustment and 5.2 × 10 −8 without). Similarly, adjusting for the 11 geographic regions did not alter the significance of the FTO association for BMI (P = 9 × 10 −6 adjusted; 8 × 10 −6 unadjusted). The minor allele frequency of rs9939609 differs very little across our studies from Finland, Italy, and many different regions in the UK ranging from 0.38 to 0.40 in all except the secondsmallest study, where it was 0.44. We found no significant regional variation in allele frequency in UK type 2 diabetic patients, whether testing 4 (P = 0.41) or 11 (P = 0.22) geographical regions of residence. For all these reasons, we do not believe that stratification/structure effects provide a realistic interpretation of our findings.
We have shown that common variation in the FTO gene is reproducibly associated with BMI and obesity from childhood into old age. SNP rs9939609 lies within the first intron of the FTO gene and, based on information from HapMap, is highly correlated (r 2 > 0.5), with 45 additional SNPs within a 47-kb region that encompasses parts of the first two introns as well as exon 2 of FTO. There are no features to suggest that any of these SNPs represents the functional variant. Linkage disequilibrium between the BMI-associated SNPs and other variants falls rapidly outside the 47-kb region, such that there are no SNPs correlated at r 2 > 0.2 outside a 90-kb interval (Fig. 1 and fig.  S2 ). Sequencing of 47 individuals selected for BMI > 40 kg/m 2 has revealed no clear candidate functional variants in the FTO coding region and minimal splice sites or 3′ UTR to explain the association (table S4) . FTO is closely adjacent to a gene of unknown function KIAA1005 (Fig. 1 and fig. S2 ), which is transcribed in the opposite direction. This opens up the possibility that genetic variation affects a regulatory element for KIAA1005; however, there is no obvious such variant within the 47-kb associated region. We conclude that the 47-kb intron within the FTO gene is most likely to contain the predisposing variant(s), but there is, at present, no clear genetic mechanism to explain how this alters the function or expression of FTO, KIAA1005, or more distant genes.
FTO is a gene of unknown function in an unknown pathway that was originally cloned as a result of the identification of a fused-toe (Ft) mutant mouse that results from a 1.6-Mb deletion of mouse chromosome 8 (18) . Three genes of unknown function (Fts, Ftm and Fto), along with three members of the Iroquois gene family (Irx3, Irx5, and Irx6 from the IrxB gene cluster), are deleted in Ft mice (18) . The homozygous Ft mouse is embryonically lethal and shows abnormal development, including left/right asymmetry (19) . Heterozygous animals survive and are characterized by fused toes on the forelimbs and thymic hyperplasia but have not been reported to have altered body weight or adiposity (19) . The fused-toe mutant is a poor model for studying the role of altered Fto activity, because multiple genes are deleted. Neither isolated inactivation nor overexpression of Fto has been described.
We used reverse transcription PCR to assess the expression of FTO and KIAA1005 in a human tissue panel (18) . FTO was found to be widely expressed in fetal and adult tissues, with expression highest in the brain (fig. S3A ). The transcription start site of KIAA1005 lies only 200 base pairs from the 5′ end of FTO and~61 kb from the 47-kb interval containing the BMI associations. KIAA1005 is also ubiquitously expressed with relatively high levels in hypothalamus and islet ( fig. S3B ). The similarity of expression profile between these two transcripts may indicate joint transcriptional regulation but does not provide insights into which of the two genes is more likely to be involved. Further work with both knockout and overexpression models of FTO and KIAA1005 are likely to provide the most fruitful approach to understanding the mechanism and pathways whereby these variants influence the risk of obesity.
assistance of many colleagues involved in sample collection, phenotyping, and DNA extraction in all the different studies. We thank K. Parnell, C. Kimber, A. Murray, K. Northstone, and C. Boustred for technical assistance. We thank S. Howell, M. Murphy, and A. Wilson (Diabetes UK) for their long-term support for these studies. We also acknowledge the efforts of J. Collier, P. Robinson, S. Asquith, and others at Kbiosciences. The flapping flight of animals generates an aerodynamic footprint as a time-varying vortex wake in which the rate of momentum change represents the aerodynamic force. We showed that the wakes of a small bat species differ from those of birds in some important respects. In our bats, each wing generated its own vortex loop. Also, at moderate and high flight speeds, the circulation on the outer (hand) wing and the arm wing differed in sign during the upstroke, resulting in negative lift on the hand wing and positive lift on the arm wing. Our interpretations of the unsteady aerodynamic performance and function of membranous-winged, flapping flight should change modeling strategies for the study of equivalent natural and engineered flying devices.
B
ats and birds represent two independent evolutionary pathways solving the same problem: powered vertebrate flight. The smaller species show similar wing morphology, kinematics, and flight speeds and operate at similar Reynolds number (1). However, the wings of bats and birds also differ in some important respects. For example, the primary feathers of a bird wing can be separated so air can pass through as in a Venetian blind to produce a feathered (and aerodynamically inactive) upstroke. Although bat wing membranes can be actively stretched and collapsed (2), they probably cannot be made aerodynamically inactive as easily as bird wing feathers. Flapping wings generate trailing vortices containing information about the time-history and magnitude of the aerodynamic force produced during the wingbeat, and so wake vortices act as an aerodynamic footprint marking the previous passage of the animal through the air (3-10). The equivalence of forces exerted between a solid object and the surrounding fluid is a consequence of Newton's laws and has long been exploited to estimate drag forces from wake momentum fluxes (11, 12) . Similarly, for a lifting body immersed in a uniform flow of speed U, the aerodynamic lift per unit of span can be written as L′ = rU G, where r is air density and G is the circulation on the wing section. In the absence of viscosity, vorticity and circulation are conserved according to Helmholtz's laws, and so any change in aerodynamic force (and hence circulation on the wing) must be associated with the shedding into the wake of vorticity of opposite sign, whose circulation matches the change on the wing.
The wake vortices of three bird species have recently been studied in some detail across wide speed ranges (8, 10, 13) , whereas those of bats have received comparatively little attention (6) . In the one qualitative study of airflows behind bats passing through a bubble cloud (6), the bats were reported to generate single vortex loops from each downstroke (with an inactive upstroke) at slow speed, whereas at a faster cruising speed, a pair of undulating vortices trailed the path of the wingtips throughout the wingbeat, implying that the upstroke generated lift. However, kinematic studies show a wingtip reversal during the upstroke during hovering and slow speed in bats (14) (15) (16) (17) (18) (19) , suggesting a reversal of the wing circulation during the upstroke, whose signature should be observable in the wake.
We made a systematic and quantitative study of the variation in wake topology and relative down-and upstroke function with flight speed in a small nectar-feeding phyllostomid bat species, Glossophaga soricina. Although detailed kinematics data are available for this species across a speed range from 1.2 to 7.5 m/s (19) , it is impossible to infer the wake vortex distribution from kinematics alone (19) . The aim was also to test the hypotheses, based on kinematics, that (i) the backward flick of the wing at slow speeds, as inferred on the basis of kinematics, generates lift and thrust (14, 16, 17, 19) ; and (ii) that the negative angle of attack during the upstroke at moderate speeds generates negative lift (14, 16, 19) . Images of the wake were analyzed by means of a digital particle image velocimetry (DPIV) method, and the quantitative measures of wake vorticity and total circulation were used to deduce the magnitude of aerodynamic forces and construct the wake topology (20) .
We studied the wakes generated by two adult G. soricina individuals across the speed range from 1. We focus our presentation of the wakes on slow (1.5 m/s), medium (4 m/s), and high (6.5 m/s) speeds, which cover the natural range of forward speeds (19, 23) . At slow speed (top row of Fig. 1 ), a strong start vortex, formed at the beginning of the downstroke, can be seen across the span (red blobs at right in Fig. 1 , A to C, marked 1 in Fig. 1A) . At the transition from downstroke to upstroke, the wing goes through a large supination (pitch-up rotation), so that the wing is flipped upside down. At this point, a combined stop-and-start vortex is shed (blue blob, left side of Fig. 1, A to C) . During the upstroke, the wing moves backward faster than the forward speed, with circulation reversed, and the induced flow in the wake is primarily a backward-directed jet. Thus, the net aerodynamic force is forward (thrust) and upward (lift). At the following transition from upstroke to downstroke, the wings pronate rapidly (a pitch-down rotation), to shed a combined start/stop vortex for the next downstroke. This start/stop vortex (2 in Fig. 1A ) appears above the previous one (1 in Fig. 1A) because the wake has convected downward in the interim. At the higher flight speed of 4 m/s, illustrated in the next two rows of Fig. 1 (panels D to F for downstroke and G to I for upstroke), the wake structure is quite different. The downstroke generates a strong start vortex (red patches in Fig. 1,  D to F) . The corresponding stop vortex is weaker and more diffuse, increasingly so as we move from outer wing (Fig. 1D) to inner wing (Fig. 1E) and body (Fig. 1F) image planes. Trace amounts of negative (blue) vorticity can be seen throughout the wingstroke. The associated induced velocity field (vectors in Fig. 1, D to F) shows a downward-and backward-directed momentum
